Global Ventricular Assist Devices Market Detail Analysis focusing on Key Players Abbott, Abiomed, Berlin Heart, Bivacor, CardiacAssist, Inc., Evaheart, Maquet, Jarvik Heart, Medtronic, Terumo Corporation
MarketStudyReport.com Adds New Ventricular Assist Devices Market 2018 – 2024 research report providing information and data By Product, By Application, By Age, By End-Use, Industry Analysis, Regional Outlook, Application Potential, Trends, Competitive Market Share & Forecast spreading across 200 Pages with table and figures in it.U.S. ventricular assist devices market is estimated to grow at robust CAGR of 9.8% over the forecast timeframe. As per the American College of Cardiology, around 800,000 die in the U.S. because of cardiovascular diseases. Growing prevalence of CVD diseases, rise in sedentary lifestyle among the people, growing heart failure rate among the Americans and recent technological advancements will be a major market driving factor in the country.
Request a sample of this report at: https://www.marketstudyreport.com/request-a-sample/1357103/
Ventricular Assist Devices Market will exceed USD 2.0 billion by 2024; as per a new research report. Japan dominated the Asia Pacific ventricular assist devices market and was valued around USD 22.0 million in the year 2017. According to recent study, the prevalence of CVD and heart failure in the people have increased at a significant rate in the past few years. The growing geriatric population prone to lifestyle diseases such as cardiovascular diseases will be responsible for the growth of ventricular assist devices in the region.
Percutaneous ventricular assist device market held significant amount of market share and was valued around USD 99.9 million in the year 2017. Increase in number of right ventricle failure rates has led to growing use of percutaneous VAD. Several advantages provided by percutaneous VAD such as safety, easy to implant and high reliability for survival will increase the demand and adoption rate of the device, augmenting the market growth.
Bridge-to-transplant (BTT) therapy market is estimated to grow substantially at a CAGR of 10.4% during the forecast period. As per the recent research reports, BTT-VAD therapy is associated with increase in patient?s survival rate and cost-effectiveness. Hence, decreased treatment and device cost will increase the adoption rate of device in the low and middle income population, fueling the business growth in the upcoming years.
The sales of ventricular assist devices in the people aged between 40-59 years of age in the year 2017 was around USD 420.2 million. The rise in prevalence of heart failure among the people of this age group will be the main reason behind the increasing sale of ventricular assist devices during the projection period.
Request a discount on standard prices of this report at: https://www.marketstudyreport.com/check-for-discount/1357103/
Recent rise in awareness about the emerging treatment and use of ventricular assist devices for heart failure in the developing region of Latin America will drive the industry growth in the near future. Growing mortality rates and hospitalization in the Latin America region due to high prevalence of heart failure rates will enhance the growth of ventricular assist devices market growth in the forthcoming years.
Lack of heart donors across the globe will be one of the major market boosting factors. According to a recent research survey, it was found that heart donation shortage is likely to increase in the near future with heart failure rate prevalence increasing multifold and heart donors growing steadily. The high prevalence of heart failure across the globe and shortage of heart donors will lead to increase in demand and adoption rate of ventricular assist devices, fueling the market growth.
Some of the leading players in the ventricular assist devices market include Abbott, Abiomed, Berlin Heart, Bivacor, CardiacAssist, Inc., Evaheart, Maquet, Jarvik Heart, Medtronic, Terumo Corporation and others. These companies focus on strategic decisions such as partnerships and collaborations to increase the research and development investment and expand their product portfolio. Merger and acquisitions have resulted in the company?s geographical expansion and boosted their efficiency to sustain in the market by providing better products.
Table of Content:
Chapter 1. Methodology
Chapter 2. Executive Summary
Chapter 3. Ventricular assist devices Industry Insights
Chapter 4. Ventricular assist devices Market, By Product
Chapter 5. Ventricular assist devices Market, By Application
Chapter 6. Ventricular assist devices Market, By Age
Chapter 7. Ventricular assist devices Market, By Region
Chapter 8. Company Profiles
For More Details On this Report: https://www.marketstudyreport.com/reports/ventricular-assist-devices-market
Related Report:
Global Ventricular Assist Devices Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
Ventricular assist device, which is also known as VAD, is a mechanically assisted pump which is being used to support heart function and flow of blood in people who have weakened hearts. Ventricular assist device works by taking blood from a lower chamber of the heart and helps pump it to the body & organs similar to a healthy heart. A VAD supports patient?s heart through or after surgery until the heart recovers, while patient is waiting for a heart transplant or if patient is not eligible for a heart transplant. A VAD can also be a long-term solution for patients with cardiac disorders.
https://www.marketstudyreport.com/reports/global-ventricular-assist-devices-market-2018-by-manufacturers-regions-type-and-application-forecast-to-2023
About Us:
Marketstudyreport.com allows you to manage and control all corporate research purchases to consolidate billing and vendor management. You can eliminate duplicate purchases and customize your content and license management.
Contact Us:
Market Study Report LLC
4 North Main Street,
Selbyville, Delaware 19975
USA
Phone: 1-302-273-0910
US Toll Free: 1-866-764-2150
Email: sales@marketstudyreport.com
Website: https://www.marketstudyreport.com
Blog: https://www.marketstudyreport.com/blog
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Ventricular Assist Devices Market Detail Analysis focusing on Key Players Abbott, Abiomed, Berlin Heart, Bivacor, CardiacAssist, Inc., Evaheart, Maquet, Jarvik Heart, Medtronic, Terumo Corporation here
News-ID: 1602330 • Views: …
More Releases from marketstudyreport.com
Load Bank Market Growth Prospectus by 2028 - Business Opportunities by ASCO Powe …
A concise assortment of data on the 'Load Bank Market' offers an exhaustive study targeting current market trends influencing the business across assorted regions. Significant details related to market size, market share, applications, and statistics are put together to convey an ensemble prediction of the industry. The research further focuses on comprehensive competitor analysis in addition to highlighting growth strategies embraced by market leaders.
Load Bank Market Size was estimated…
Agriculture Equipment Market is Expected to Reach USD 161640 Million by 2028 - J …
Global Agriculture Equipment Market with respect to the pivotal drivers influencing the revenue graph of this business sphere. The current trends of the market with the geographical landscape, demand, remuneration scale, and growth of this vertical have also been included in this report.
Global Agriculture Equipment Market Size was estimated at USD 114110 million in 2021 and is projected to reach USD 161640 million by 2028, exhibiting a CAGR of…
Electric Vehicle Market Size to grow at a CAGR of 23.5% through 2028| Tesla Inc. …
Global Electric Vehicle Market with respect to the pivotal drivers influencing the revenue graph of this business sphere. The current trends of market with the geographical landscape, demand, remuneration scale, and growth of this vertical have also been included in this report.
The electric vehicles (EVs) market is estimated to witness a robust growth rate of 23.5% during the period 2019-2028.
The operation is done to stop ligament tears and…
Fuel Cell Air Compressor Market is Expected to Reach USD 512.3 Million by 2028 - …
Global Fuel Cell Air Compressor Market with respect to the pivotal drivers influencing the revenue graph of this business sphere. The current trends of market with the geographical landscape, demand, remuneration scale, and growth of this vertical have also been included in this report.
Global Fuel Cell Air Compressor Market Size was estimated at USD 215.1 million in 2021 and is projected to reach USD 512.3 million by 2028, exhibiting…
More Releases for Ventricular
Ventricular Assist Device Market Report Up tp 2031
Visiongain has published a new report on Ventricular Assist Device Market Report 2021-2031: Forecasts by Product (LVAD, RVAD, BiVAD, TAH), By Type of Flow (Pulsatile, Continuous), By Design, By Application. PLUS Profiles of Leading Pharma Contract Manufacturing Companies and Regional and Leading National Market Analysis. PLUS COVID-19 Recovery Scenarios.
GlobalVentricular Assist Device market was valued at US$ xx billion in 2020 and is projected to reach at a market value of…
Left Ventricular Dysfunction - Pipeline Review, H1 2018
Left Ventricular Dysfunction
Overview
Left ventricular dysfunction is the most common cause of congestive heart failure. Symptoms include fluid retention, dizziness, fatigue, weakness, irregular heart beat and congested lungs. Risk factors include high blood pressure, diabetes, sleep apnea, alcoholism and Left Ventricular Dysfunction.
Click here for sample report @ https://www.wiseguyreports.com/sample-request/2811435-left-ventricular-dysfunction-pipeline-review-h1-2018
Top Companies mentioned
Bayer AG
Innopharmax Inc
Mesoblast Ltd
Novartis AG
Quantum Genomics SA
TiGenix NV
Left Ventricular Dysfunction Industry Major Outlook
Pharmaceutical and Healthcare latest pipeline guide Left Ventricular Dysfunction -…
Left Ventricular Dysfunction - Pipeline Review, H1 2017
Publisher's latest Pharmaceutical and Healthcare disease pipeline guide Left Ventricular Dysfunction - Pipeline Review, H1 2017, provides an overview of the Left Ventricular Dysfunction (Cardiovascular) pipeline landscape.
Left ventricular dysfunction is the most common cause of congestive heart failure. Symptoms include fluid retention, dizziness, fatigue, weakness, irregular heart beat and congested lungs. Risk factors include high blood pressure, diabetes, sleep apnea, alcoholism and coronary artery disease.
Report Highlights
Publisher's Pharmaceutical and Healthcare…
Global Ventricular Fibrillation Market 2021- Analysis and Trends
“Global Ventricular Fibrillation Market Research Report” Purchase This Report by calling ResearchnReports.com at +1-888-631-6977.
Ventricular fibrillation is a heart rhythm problem that occurs when the heart beats with rapid, erratic electrical impulses. This causes pumping chambers in your heart (the ventricles) to quiver uselessly, instead of pumping blood. Together, all four chambers pump blood to and from the body. When the atria, the two upper chambers, contract at an excessively high…
Ventricular Assist Devices (VAD) Market Assessment
Ventricular assist devices (VAD) are mechanical pumps used to support patients with a weakened heart or in case of heart failure to temporarily maintain heart function. The devices helps in re-establishing normal hemodynamics under conditions involving damaged ventricle. Increasing trend for sedentary lifestyle, rising obesity population globally, lifestyle changes and various other factors have resulted an increase in cardiovascular disorders. This rising prevalence across the globe has been a major…
Ventricular Assist Device Market: Global Markets & Advanced Technologies
North America Ventricular Assist Device Market: Overview
Advance Heart Failure is characterized as weakening of the heart caused due to failure of the left ventricle, due to which the heart is unable to pump blood to different parts of the body. According to the AHA (American Heart Association), 5.7 Mn people in the U.S suffer from heart failure and 300,000 die each year of heart failure. Moreover, the AHA predicts…